A cohort study of neonatal hearing testing and genetic screening for variants associated with susceptibility to aminoglycoside antibiotic-induced hearing loss in Beijing, China.

Abstract excerpt

Genetic variants, many of which are in mitochondrial DNA (mtDNA), contribute to hearing loss. Screening for these variants facilitates the identification of potential carriers, as many people with these mutations do not show hearing loss at birth but show late-onset hearing loss. We conducted a population-based cohort study involving 180,458 neonates born in Beijing, China. Hearing screening was performed through...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Aminoglycosides
• Share to Anti-Bacterial Agents